Global Expansion GTI is expanding manufacturing capacity in Asia with a newly commissioned plant in Jakarta, Indonesia, and investments in a Sucralfate plant in Gujarat, India. This regional expansion supports supply security and proximity to growing markets, creating opportunities to partner with pharma, life sciences, and personal care customers who need localized and reliable sourcing with shorter lead times.

Pharma Focus GTI operates across Personal Care, Water Treatment, Pharmaceutical and Life Science markets and has invested in pharmaceutical grade capability such as the Sucralfate plant in Gujarat. Its engagement with vaccine and global health communities, through events like World Immunization Day and the DCVMN General Meeting, signals opportunities to win pharma and vaccine manufacturing collaborations and CDMO engagements.

Reliability Advantage With a mission built on trust, responsiveness and innovation and a track record of on time delivery, GTI offers a reliability advantage for customers in regulated industries. The four decade global experience supports scalable capacity and consistent performance across regions, which is attractive to customers seeking dependable supply chains.

Vaccine Supply Fit GTI's alignment with immunization programs and vaccine supply chain forums suggests potential as a strategic supplier for vaccine related chemistries and pharmaceutical manufacturing inputs. This positions GTI to collaborate with governments, NGOs and vaccine manufacturers seeking secure, compliant sourcing and steady capacity.

Digital Compliance Readiness GTI's technology footprint and IT oriented operations indicate readiness to integrate with customers' digital systems, provide data traceability and meet regulatory standards. This makes GTI an attractive partner for mid market pharma and life science customers looking for scalable, auditable manufacturing and strong compliance support.